We are live on ! Find out more
VLKIM

Van Lanschot Kempen Investment Management Portfolio holdings

AUM $11.4B
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+16.77%
3 Year Est. Return
+63.28%
5 Year Est. Return
+82.06%
10 Year Est. Return
+190.54%
AUM
$10.5B
AUM Growth
+$920M
Cap. Flow
-$64.6M
Cap. Flow %
-0.62%
Top 10 Hldgs %
40.97%
Holding
262
New
34
Increased
109
Reduced
86
Closed
23

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$100M
2
LEN icon
Lennar Class A
LEN
+$88.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$82.1M
4
LFUS icon
Littelfuse
LFUS
+$65.8M
5
KKR icon
KKR & Co
KKR
+$54M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$150M
2
MDT icon
Medtronic
MDT
+$149M
3
AVTR icon
Avantor
AVTR
+$89.3M
4
MA icon
Mastercard
MA
+$42.5M
5
HBAN icon
Huntington Bancshares
HBAN
+$36.5M

Sector Composition

Rank Sector Weight
1 Technology 28.31%
2 Financials 21.4%
3 Consumer Discretionary 13.45%
4 Communication Services 13.1%
5 Healthcare 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNH
51
CNH Industrial
CNH
$17.3B
$36.2M 0.35%
2,795,424
-77,462
-3% -$957K
MWA icon
52
Mueller Water Products
MWA
$4.09B
$35.4M 0.34%
1,472,015
+103,292
+8% +$2.56M
LLY icon
53
Eli Lilly
LLY
$1.09T
$35M 0.33%
44,903
-5,841
-12% -$4.54M
TXN icon
54
Texas Instruments
TXN
$253B
$35M 0.33%
168,367
-25,339
-13% -$4.5M
DOC icon
55
Healthpeak Properties
DOC
$14.2B
$34.3M 0.33%
1,961,107
-1,533,617
-44% -$27.2M
PEP icon
56
PepsiCo
PEP
$189B
$33.7M 0.32%
255,424
+45,985
+22% +$6.19M
RNR icon
57
RenaissanceRe
RNR
$13.2B
$33.7M 0.32%
138,778
-107,199
-44% -$26M
FSLR icon
58
First Solar
FSLR
$24.4B
$33.6M 0.32%
203,138
+41,891
+26% +$6.18M
SPG icon
59
Simon Property Group
SPG
$71.4B
$32.9M 0.31%
204,740
+103,036
+101% +$16.3M
THR
60
DELISTED
Thermon Group Holdings
THR
$32.9M 0.31%
1,171,120
-271,350
-19% -$7.35M
EQIX icon
61
Equinix
EQIX
$105B
$32.2M 0.31%
40,434
+11,042
+38% +$9.37M
GNTX icon
62
Gentex
GNTX
$4.93B
$31.4M 0.3%
1,428,979
-68,768
-5% -$1.5M
NE icon
63
Noble Corp
NE
$7.04B
$31.1M 0.3%
1,170,994
+179,319
+18% +$4.3M
OMC icon
64
Omnicom Group
OMC
$23.5B
$30M 0.29%
416,709
+237,178
+132% +$17.5M
MDT icon
65
Medtronic
MDT
$116B
$29.9M 0.29%
343,354
-1,759,696
-84% -$149M
GILD icon
66
Gilead Sciences
GILD
$168B
$29.9M 0.28%
269,598
-57,692
-18% -$6.14M
NXST icon
67
Nexstar Media Group
NXST
$5.7B
$28.3M 0.27%
163,667
-51,075
-24% -$8.37M
PG icon
68
Procter & Gamble
PG
$335B
$28.2M 0.27%
176,907
-8,302
-4% -$1.36M
MSM icon
69
MSC Industrial Direct
MSM
$6.67B
$28.2M 0.27%
331,405
+15,707
+5% +$1.24M
HOLX
70
DELISTED
Hologic
HOLX
$28.1M 0.27%
+431,956
New +$25.9M
FHN icon
71
First Horizon
FHN
$12.3B
$27.6M 0.26%
1,302,537
+820,405
+170% +$15.6M
PRU icon
72
Prudential Financial
PRU
$42.3B
$27.6M 0.26%
256,857
+1,564
+0.6% +$162K
LYB icon
73
LyondellBasell Industries
LYB
$20.3B
$27.5M 0.26%
475,847
-15,260
-3% -$889K
ACN icon
74
Accenture
ACN
$110B
$27.4M 0.26%
91,517
+14,851
+19% +$4.52M
PEG icon
75
Public Service Enterprise Group
PEG
$37.8B
$26.9M 0.26%
318,991
-3,856
-1% -$311K

Similar funds

Van Lanschot Kempen Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Van Lanschot Kempen Investment Management held 262 positions worth $10.5B, up 9.6% from $9.58B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Van Lanschot Kempen Investment Management's Q2 2025 filing shows 34 new, 109 increased, 86 reduced and 23 closed positions. Its largest new stake was NVR: 13,962 shares worth $103M. The largest sale was Johnson & Johnson, an estimated $150M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Van Lanschot Kempen Investment Management's largest Q2 2025 buy was NVR: 13,962 shares worth $103M.
  • Van Lanschot Kempen Investment Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $82.1M increase.
  • Van Lanschot Kempen Investment Management's biggest Q2 2025 reduction was Medtronic, cutting an estimated $149M.
  • Van Lanschot Kempen Investment Management fully exited Johnson & Johnson in Q2 2025, selling an estimated $150M.
  • Van Lanschot Kempen Investment Management's ten largest holdings make up 41% of its $10.5B portfolio in Q2 2025.
  • Van Lanschot Kempen Investment Management opened 34 new positions and closed 23 in Q2 2025.
  • Van Lanschot Kempen Investment Management's portfolio value rose 9.6% quarter-over-quarter to $10.5B.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.